Evaluating alcohol use in patients with alcoholic liver disease
Evaluating Alcohol Use in Alcoholic Liver Disease
This study is trying to see how often people with alcoholic liver disease go back to drinking alcohol over a period of up to 10 years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 160 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | New York Presbyterian Hospital Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT03267069 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate alcohol recidivism in patients diagnosed with alcoholic liver disease, including acute alcoholic hepatitis and alcoholic cirrhosis. Adult subjects presenting at Weill Cornell Medical Center or Columbia University Medical Center will be invited to participate. The study involves a baseline survey followed by multiple follow-up assessments over a period of up to 10 years, which will include chart reviews and interviews to track alcohol use patterns. Clinical providers will remain blinded to the survey results to ensure unbiased data collection.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with alcoholic liver disease who are able to provide informed consent.
Not a fit: Patients without alcoholic liver disease or those unable to consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into alcohol use patterns and recidivism, potentially informing better treatment strategies for patients with alcoholic liver disease.
How similar studies have performed: While this approach is observational and builds on existing knowledge, similar studies have shown success in understanding alcohol use patterns in liver disease patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * alcoholic liver disease able to consent Exclusion Criteria: * without alcoholic liver disease unable to consent
Where this trial is running
New York, New York
- New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Robert S Brown, MD, MPH — New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center
- Study coordinator: Nicole T Shen, MD
- Email: nts9004@nyp.org
- Phone: 3146095911
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.